Right- and left-sided colorectal cancers respond differently to cetuximab

INTRODUCTION: Right-sided colon cancer (RSCC) and left-sided colorectal cancer (LSCRC) differ with respect to their biology and genomic patterns. This study aimed to examine whether the primary tumor location is associated with the response to cetuximab in patients with metastatic colorectal cancer...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Chin J Cancer
Главные авторы: Wang, Feng, Bai, Long, Liu, Tian-Shu, Yu, Yi-Yi, He, Ming-Ming, Liu, Kai-Yan, Luo, Hui-Yan, Zhang, Dong-Sheng, Jin, Yin, Wang, Feng-Hua, Wang, Zhi-Qiang, Wang, De-Shen, Qiu, Miao-Zhen, Ren, Chao, Li, Yu-Hong, Xu, Rui-Hua
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4593341/
https://ncbi.nlm.nih.gov/pubmed/26111811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-015-0022-x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы